 Predictive Oncology Inc has announced the appointment of Raymond Vennare as the companys new CEO and board chairman, effective November 1, 2022. The company said Vennare, an active member of the Predictive Oncology board of directors since September 2021, will continue to work closely with senior management to expand its portfolio of proprietary solutions to advance the pipeline of drug development in oncology, ranging from early discovery through clinical trials. 